Clinical Trials Directory

Trials / Completed

CompletedNCT03782883

The Impact of Charcot-Marie-Tooth Disease in the Real World

Status
Completed
Phase
Study type
Observational
Enrollment
3,321 (actual)
Sponsor
Vitaccess Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An observational, non-interventional registry study to collect real-world data from people living with Charcot-Marie-Tooth disease (CMT) and its treatment, which will be available to researchers to further the knowledge of Charcot-Marie-Tooth disease and improve patient care.

Detailed description

The registry uses Vitaccess' digital real-world evidence platform and has been developed in collaboration with CMT experts, Patient Advocacy Organizations (PAOs) and the biopharmaceutical company Pharnext. Eligible participants install a study app on their smartphone. Researchers access aggregated, anonymised data via a cloud-based research portal. The platform provides benefits to participants, which it is hoped will encourage persistence with data submission; these include options to download a copy of their symptom diary, a clinically-validated Knowledge feature, and access to high-level results from the study data. The aggregated data are available in close to real time via "dashboards" and can be analysed according to a number of pre-set criteria (e.g. disease stage, age, geographic location). State-of-the-art technologies and security policies are used in the platform to ensure industry-standard data storage and privacy for all users. Participants' personally identifiable information will remain confidential at all times, and researchers will not be able to identify individuals. The study is ethics-approved in all scope countries and led by a Scientific Advisory Board comprising representatives from international PAOs, patients and key opinion leaders from each country, and study leads from both Pharnext Société Anonyme (SA) and Vitaccess Ltd.

Conditions

Timeline

Start date
2018-10-09
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2018-12-20
Last updated
2024-11-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03782883. Inclusion in this directory is not an endorsement.